Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 912 of 5804
-
New brain implant could ease walking and thinking problems in older adults
Disease control OngoingThe eShunt System includes proprietary delivery componentry and the eShunt Implant, a permanent implant deployed in a minimally invasive, neurointerventional procedure. The eShunt Implant is designed to mimic the function of the arachnoid granulations by draining excess cerebrosp…
Phase: NA • Sponsor: CereVasc Inc • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Liver cancer drug shows promise in Late-Stage patients
Disease control CompletedTo investigate the efficacy and safety of sorafenib administered as later lines of treatment in patients with advanced HCC.
Phase: PHASE2 • Sponsor: Bo Hyun Kim • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
New scan may spare men from unnecessary prostate biopsies
Diagnosis OngoingThis clinical trial will evaluate PSMA PET additive value for significant prostate cancer (sPCa) diagnosis in men with negative/equivocal MRI
Phase: PHASE3 • Sponsor: Peter MacCallum Cancer Centre, Australia • Aim: Diagnosis
Last updated Jun 27, 2026 09:09 UTC
-
Stent vs. shunt: which brain pressure fix saves sight best?
Disease control Recruiting nowIdiopathic intracranial hypertension (HTICi) is a pathology, affecting young adults with a predominance of women, due to an increase in intracranial pressure, which may be associated with stenosis of the cerebral venous sinuses and whose origin remains unknown. This hypertension…
Phase: NA • Sponsor: Fondation Ophtalmologique Adolphe de Rothschild • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
New immunotherapy combo targets Hard-to-Treat cancers
Disease control Recruiting nowThe SERPENTINE trial (ESR 21-21165) is a phase II clinical study aiming to evaluate the efficacy of durvalumab and tremelimumab, alone or in combination, in patients with colorectal or endometrial cancer. The trial targets patients with microsatellite instability-high (MSI-H) tum…
Phase: PHASE2 • Sponsor: Vall d'Hebron Institute of Oncology • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Robotic surgery may replace chemo for testicular cancer
Disease control Recruiting nowThis study will investigate the safety and efficacy of using robotic retroperitoneal lymph node dissection (R-RPLND), a minimally invasive surgical approach, as the first-line of treatment for stage IIA/B (or equivalent) seminoma patients. R-RPLND will be trialed as an alternativ…
Phase: NA • Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
New drug combo aims to boost myeloma treatment
Disease control OngoingThe purpose of this research study is to determine if two drugs approved for treating multiple myeloma, belantamab mafodotin and elotuzumab, are safe and more effective when used together.
Phase: PHASE1, PHASE2 • Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
New proton beam therapy aims to zap head and neck cancer with fewer side effects
Disease control OngoingThis clinical trial studies how well intensity modulated proton therapy (IMPT) or intensity modulated X-ray (radiation) therapy (IMRT) works after surgery in treating patients with head and neck cancer. IMPT is a type of radiation therapy that allows for the most accurate applica…
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
Wireless pacemaker shows promise for Dual-Chamber pacing
Disease control CompletedProspective, non-randomized, multi-center, international study designed to evaluate the safety and effectiveness of the Aveir™ Dual-Chamber (DR) Leadless Pacemaker system.
Phase: NA • Sponsor: Abbott Medical Devices • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
Heart attack patients: which blood thinner is safer?
Disease control CompletedThis study proposes to conduct the switch from ticagrelor to prasugrel in an organized stepwise manner, to allow for the evaluation of the relative efficacy of prasugrel versus ticagrelor using a stepped-wedge cluster randomized trial design.
Phase: PHASE4 • Sponsor: Vastra Gotaland Region • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
New mammogram technique could spare thousands from unneeded breast biopsies
Diagnosis Recruiting nowOne of the primary criticisms of mammography is that it leads to unneeded stress and anxiety from identification and biopsy of non-cancerous findings. Contrast-enhanced mammography (CEM) has the potential to significantly reduce biopsy rates for commonly seen benign breast lesion…
Phase: PHASE4 • Sponsor: Margarita Louise Zuley • Aim: Diagnosis
Last updated Jun 27, 2026 07:54 UTC
-
New hope for Hard-to-Treat HER2 cancers? early trial launches
Disease control Recruiting nowThis is a dose-escalation and dose-expansion Phase 1/2a trial to evaluate the safety and tolerability of DB-1303/BNT323 in subjects with advanced solid tumors that express HER2.
Phase: PHASE1, PHASE2 • Sponsor: DualityBio Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Could a pill boost brain function in Huntington's? new trial tests SAGE-718
Symptom relief CompletedThe primary purpose of this study is to evaluate the effect of SAGE-718 on cognitive performance and functioning in participants with HD.
Phase: PHASE2 • Sponsor: Supernus Pharmaceuticals, Inc. • Aim: Symptom relief
Last updated Jun 26, 2026 17:09 UTC
-
New hope for kidney patients with Hard-to-Match immune systems
Disease control TerminatedWhile the number of kidney transplants is increasing worldwide every year, there is a clear imbalance between the high number of patients in the waiting list and those receiving a transplant and importantly, among waitlist patients there is a progressively higher number of highly…
Phase: PHASE2 • Sponsor: University Hospital, Grenoble • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
New pill shows promise for stubborn depression
Symptom relief CompletedThis study will evaluate the efficacy and safety of NV-5138 in adults with TRD
Phase: PHASE2 • Sponsor: Navitor Pharmaceuticals, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 12:09 UTC
-
Could a seizure drug curb alcohol cravings? new trial investigates
Disease control OngoingA phase II randomized, double-blind, placebo-controlled clinical trial (RCT) to evaluate the ability of zonisamide (ZON) to decrease alcohol use among treatment-seeking adults with an alcohol use disorder (AUD).
Phase: PHASE2 • Sponsor: Washington State University • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
New drug targets aggressive brain tumors in phase II trial
Disease control Recruiting nowThis is an open-label single arm study. All patients will receive the study drug. The aim of the study is to compare overall survival (OS) of patients with recurrent brain tumor, known as Glioblastoma (GBM) having high levels of a protein, Trophoblast cell surface antigen 2 (Trop…
Phase: PHASE2 • Sponsor: The University of Texas Health Science Center at San Antonio • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Experimental drug SHR-A2009 takes first steps against Hard-to-Treat cancers
Disease control OngoingThis study is an open-label, multicenter Phase I clinical trial to evaluate the safety, tolerability, pharmacokinetics and efficacy of SHR-A2009 for injection in patients with advanced solid tumors.
Phase: PHASE1 • Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
Microwave ablation boosts immunotherapy in advanced liver cancer study
Disease control CompletedImmunotherapy has become the main treatment recommendation for HCC. MWA treatment induces peripheral immune response, which may enhance the effectiveness of immunotherapy for advanced HCC. This study aims to compare the efficacy and safety of ICIs combined with MWA compared to IC…
Sponsor: The First People's Hospital of Neijiang • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
New surgical twist may save sight in babies with rare glaucoma
Disease control CompletedPrimary congenital glaucoma (PCG) is a vision-threatening disorder of childhood characterized by elevated intraocular pressure (IOP) resulting from developmental abnormalities of the anterior chamber angle. Early surgical intervention is the standard treatment to preserve visual …
Phase: NA • Sponsor: Benha University • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC